Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 736588Erstellt: 24. Oktober 2026

Piperazine → 4-(3-Carboxy4-chloro-benzenesulfonyl)-piperazine-1-carboxylic acid ethyl ester

https://huagongshe.com/de/reaction/736588

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktPiperazineHCID 4837—
Edukt1-Piperazinecarboxylic acid, ethyl esterHCID 8431—
EduktSulfuryl fluorideHCID 17607—
EduktDiisopropylethylamineHCID 81531—
Edukt2-Chloro-5-(fluorosulpho)benzoic acidHCID 88873—
LösungsmittelEthyl AcetateHCID 8857—
Produkt4-(3-Carboxy4-chloro-benzenesulfonyl)-piperazine-1-carboxylic acid ethyl esterHCID 4546423180,8%

Reaktionsschritte

2-Chloro-5-fluorosulfonylbenzoic acid (Acros Organics, 105 mg, 440 μmol, 1.0 eq) was placed in a vial and the vial was flushed with nitrogen and a positive pressure was maintained. Anhydrous dichloromethane (1.4 mL) was added, followed by ethyl 1-piperazine carboxylate (80 μL, 528 μmol, 1.2 eq) and ethyldiisopropylamine (redistilled, 80 μL, 440 μmol, 1.0 eq). The mixture was stirred for 1.5 h after which time additional piperazine was added (60 μL, 352 μmol, 0.8 eq). After 14 h the mixture was analyzed by reverse-phase HPLC-MS in negative ionization mode. The sulfonyl fluoride starting material was present, as well as a less polar compound showing (M−1) ion in about 35:65 ratio. An additional 0.35 eq of piperazine and ethyldiisopropylamine each (154 μmol, 30 μl) were added and the mixture was stirred for 4 h. HPLC-MS at this time indicated little progress and an additional 0.25 eq of piperazine (100 mmol, 20 μL) was added. After stirring for 14 h HPLC-MS indicated the reaction was complete. The reaction mixture was diluted with 2 mL of ethyl acetate, washed with 1 M HCl solution (2×1 mL) and dried over anhydrous sodium sulfate. The solution was filtered, the solvents removed on a rotary evaporator and vacuum pump to afford 134 mg of a white solid, 81%. NOTE: Addition of excess nucleophilic amine at the beginning of the reaction results in significant bis addition, giving sulfonamide and carboxamide product. Stepwise addition of nucleophilic amine as needed suppresses formation of this side product.

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS07595322B2
Quelldatensatzuspto-grants-2009_09
ORD IDord-070992a714864dfe8ab9af9c40a17477
Quellennotizuspto-grants-2009_09